Therefore, further investigations of the role of differential CD32b expression on these B cell subpopulations in the context of EBV infection and MS immunopathogenesis are warranted, particularly their roles in activation and/or regulation of T cell responses. This evidence concerns the gene FCGR2B and myeloid sarcoma.